FDA Adverse Event Injury Summary report: N

NEUROFORM EZ¿ 3

MDR report key: 2250361 · Received September 15, 2011

Report

Report Number
2939204-2011-00432
Event Type
Injury
Date Received
September 15, 2011
Date of Event
August 19, 2011
Report Date
August 24, 2011
Manufacturer
BOSTON SCIENTIFIC - CORK
Product Code
NJE
PMA / PMN Number
H020002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A DEVICE HISTORY RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE DEVICE REMAINS IMPLANTED SO WAS NOT AVAILABLE FOR EVALUATION. FROM THE INFORMATION PROVIDED THERE IS NO INDICATION THAT THERE WAS ANY DEVICE MALFUNCTION, NONCONFORMANCE OR MISUSE THAT CONTRIBUTED TO THE REPORTED EVENT. THROMBOSIS AND HEMORRHAGE ARE KNOWN AND ANTICIPATED COMPLICATIONS TO THESE TYPES OF PROCEDURES AND ARE LISTED AS SUCH IN THE DIRECTIONS FOR USE. THEREFORE IT WAS DETERMINED THAT THE REPORTED EVENT WAS AN ANTICIPATED PROCEDURAL COMPLICATION.

Description of Event or Problem · 1

IT WAS REPORTED THAT PATIENT DEVELOPED A THOMBUS IN A BRANCH OFF THE POSTERIOR CEREBRAL ARTERY DURING THE STENT ASSISTED COIL EMBOLIZATION PROCEDURE. REOPRO WAS ADMINISTERED TO TREAT THE THROMBUS. NO OTHER INFORMATION WAS PROVIDED.

Description of Event or Problem · 1

IT WAS REPORTED THAT PATIENT DEVELOPED A THOMBUS IN A BRANCH OFF THE POSTERIOR CEREBRAL ARTERY AFTER THE STENT WAS IMPLANTED, THERE WAS NO INSTENT THROMBOSIS. REOPRO WAS ADMINISTERED TO TREAT THE THROMBUS AND THE THROMBUS WAS FULLY RESOLVED. THE PATIENT SUFFERED SECONDARY BLEEDING DUE TO THE REOPRO THAT WAS ADMINISTERED TO TREAT THE THROMBUS. NO OTHER INFORMATION REGARDING THE PATIENT'S CONDITION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 NEUROFORM EZ¿ 3 STENT, INTRACRANIAL NEUROVASCULAR NJE BOSTON SCIENTIFIC - CORK M003N3EZ25150 13872174

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention